Showing results (631-640 of 1,369) with videos related to
Sort By:
Pageof 137
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|February 1, 1996
Human pregnancy serum suppresses the proliferative response of lymphocytes to autologous PHA-activated T lymphoblastsR Wolf-Levin, K Aoki, T Azuma, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 14, 1999
Complement-mediated anti-HIV-1 effect induced by human IgM monoclonal antibody against ganglioside GM2X Wu, N Okada, H Momota, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1988
The C4 and C2 but not C1 components of complement are responsible for the complement activation triggered by the Ra-reactive factorY H Ji, M Matsushita, H Okada, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1988
[Restorative effect of muroctasin, MDP-Lys (L 18), on leukopenia caused by anticancer chemotherapy in lung cancer--comparative study by envelope method]M Takada, M Fukuoka, N Takifuji, et al.European Journal of Immunology|September 1, 1987
Functional interleukin 2 receptors on B cells lacking Tac antigensT Tanaka, O Saiki, S Doi, et al.Journal of the National Cancer Institute|August 21, 1991
Phase I study of weekly intravenous infusions of CPT-11, a new derivative of camptothecin, in the treatment of advanced non-small-cell lung cancerS Negoro, M Fukuoka, N Masuda, et al.British Journal of Cancer|August 15, 2002
Dose-escalation study of weekly irinotecan and daily carboplatin with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancerM Yamada, S Kudoh, H Fukuda, et al.Japanese Journal of Cancer Research : Gann|February 1, 1993
Enhanced antitumor efficacy of a combination of CPT-11, a new derivative of camptothecin, and cisplatin against human lung tumor xenograftsS Kudoh, M Takada, N Masuda, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1987
[Studies on the appropriate administration of cisplatin based on pharmacokinetics and toxicity]K Kitajima, M Fukuoka, S Kobayashi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1992
CPT-11 in combination with cisplatin for advanced non-small-cell lung cancerN Masuda, M Fukuoka, M Takada, et al.Pageof 137